NCT03792126

Brief Summary

This trial will compare an Implicit Learning Approach (ILA) to usual care, during the rehabilitation of mobility post stroke. It is a multicentre, assessor blind, cluster randomised controlled pilot trial, with embedded feasibility study. It also includes a nested qualitative evaluation, designed to explore the views of participants and therapists.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 3, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 24, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 24, 2022

Completed
2.9 years until next milestone

Results Posted

Study results publicly available

December 13, 2024

Completed
Last Updated

December 13, 2024

Status Verified

October 1, 2024

Enrollment Period

2.9 years

First QC Date

December 19, 2018

Results QC Date

August 8, 2024

Last Update Submit

October 31, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Modified Rivermead Mobility Index Score

    Measure of functional mobility in people with stroke. Ordinal scale, measured through direct observation of function. Score range from 0-40, with a higher score indicating better functional mobility status.

    12 weeks

Secondary Outcomes (1)

  • Swedish Postural Adjustment in Stroke Scale (SwePASS)

    Week 0, 2 and 12

Other Outcomes (3)

  • Fugl Meyer - Motor Leg Sub Section

    Week 0, week 2 and week 12

  • Modified Rankin Score

    Week 0, Week 12

  • EuroQOL 5 D Questionnaire Index Score

    3 months

Study Arms (2)

Standard Care

NO INTERVENTION

Standard care, as per usual working practice for the stroke unit. Control stroke units will have minimal contact with the research team, other than for data collection. They will be aware of the broad aims of the study, but not the specific detail of the intervention.

Implicit Learning Approach

EXPERIMENTAL

All mobility focussed rehabilitation sessions will utilise the Implicit Learning approach (ILA), as usual care. This includes rehabilitation (delivered by a physiotherapist, occupational therapist or therapy assistant) that focusses on sitting, sit to stand, standing, stepping, transfers and walking. The content of therapy will be based on the treatment guidelines and intervention manual, which have been developed by an international expert group (using Delhi methodology). As this is a clinically grounded, pragmatic trial, therapists will have freedom to tailor the specific content of each treatment session to patient need, whilst remaining true to the ILA. Other therapy interventions, such as upper limb rehabilitation, will be provided as usual.

Other: Implicit Learning Approach

Interventions

All mobility focussed rehabilitation sessions will utilise the Implicit Learning Approach (ILA), as usual care. This includes rehabilitation (delivered by a physiotherapist, occupational therapist or therapy assistant) that focusses on sitting, sit to stand, standing, stepping, transfers and walking. The content of therapy will be based on the treatment guidelines and intervention manual - and primarily involves changing the quantity and focus of attention of instructions and feedback. As this is a clinically grounded, pragmatic trial, therapists will have freedom to tailor the specific content of each treatment session to patient need, whilst remaining true to the ILA.

Implicit Learning Approach

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of stroke, presenting with hemiplegia
  • Within 14 days of stroke onset
  • Medically stable
  • Able to...
  • tolerate daily therapy for a minimum of 30 minutes per session
  • sit for more than 5 seconds without support
  • understand and follow 1 stage commands

You may not qualify if:

  • Previous stroke with residual impairments
  • Other neurological diagnosis (e.g. Parkinsons Disease, Multiple Sclerosis)
  • Clinically relevant pre-morbid disability levels

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Bournemouth Hospital

Bournemouth, Dorset, BH7 7DW, United Kingdom

Location

Related Publications (3)

  • Johnson L, Mardo J, Demain S. Understanding implementation of a complex intervention in a stroke rehabilitation research trial: A qualitative evaluation using Normalisation Process Theory. PLoS One. 2023 Sep 8;18(9):e0282612. doi: 10.1371/journal.pone.0282612. eCollection 2023.

  • Johnson L, Burridge J, Ewings S, Westcott E, Gayton M, Demain S. Principles into Practice: An Observational Study of Physiotherapists use of Motor Learning Principles in Stroke Rehabilitation. Physiotherapy. 2023 Mar;118:20-30. doi: 10.1016/j.physio.2022.06.002. Epub 2022 Jun 20.

  • Johnson L, Burridge J, Demain S, Ewings S. Comparing the Impact of an Implicit Learning Approach With Standard Care on Recovery of Mobility Following Stroke: Protocol for a Pilot Cluster Randomized Controlled Trial. JMIR Res Protoc. 2019 Nov 5;8(11):e14222. doi: 10.2196/14222.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Louise Johnson
Organization
University Hospitals Dorset NHS Foundation Trust

Study Officials

  • Louise Johnson

    University Hospitals Dorset

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2018

First Posted

January 3, 2019

Study Start

March 1, 2019

Primary Completion

January 24, 2022

Study Completion

January 24, 2022

Last Updated

December 13, 2024

Results First Posted

December 13, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will share

Qualitative data has been shared via the publication with PlosOne, as part of their publishing requirements. Quantitative data will be made available, upon reasonable request, following publication of the final paper.

Shared Documents
STUDY PROTOCOL, CSR, ANALYTIC CODE
Time Frame
Following final paper publication and for the duration of the archiving period (10 years)
Access Criteria
Will be assessed upon request.

Locations